What Others Say About Pharmacogenetics & DNA Testing
- The AMA calls it “The Future of Medicine“
- Eli Lilly calls it “Tailored Therapeutics“
- Vanderbilt calls it “Personalized Medicine“
- Cornell/Columbia call it “Precision Prescribing“
“The goal of personalized medicine is to individualize health care by using knowledge of patients’ health history, behaviors, environments, and, most importantly, genetic variation when making clinical decisions.
American Medical Association
“The power in tailored therapeutics is for us to say more clearly to payers, providers, and patients – ‘this drug is not for everyone, but it is for you.’ This is exceedingly powerful.”
John C. Lechleiter, Ph.D. President & CEO, Eli Lilly and Company
“Today, one of our biggest goals is to cut the cost of sequencing an entire human genome to $1,000 or less. This advance will pave the way for each person’s genome to be sequenced as part of the standard of care, leading to a revolution in the practice of medicine.”
Francis S. Collins, M.D., Ph.D.
Director, National Institutes of Health
Pharmacogenomics has been characterized as “getting the right dose of the right drug to the right patient at the right time.”
L. Lesko, Regulatory Perspective on Warfarin Relabeling with Genetic Information